BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 14-Nov-2019

(Q1 Un-audited): Consolidated EPS was Tk. 2.13 for July-September 2019 as against Tk. 1.86 for July-September 2018; Consolidated NOCFPS was Tk. 4.59 for July-September 2019 as against Tk. 1.05 for July-September 2018. NAV per share was Tk. 75.09 as on September 30, 2019 and Tk. 68.59 as on September 30, 2018.

BXPHARMA 05-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

BXPHARMA 14-Nov-2018

(Q1 Un-audited): Consolidated EPS was Tk. 1.86 for July-September, 2018 as against Tk. 1.59 for July-September, 2017; Consolidated NOCFPS was Tk. 1.05 for July-September, 2018 as against Tk. 1.56 for July-September, 2017. Consolidated NAV per share was Tk. 68.59 as on September 30, 2018 and Tk. 63.36 as on September 30, 2017. As the company acquired Nuvista Pharma on 2.4.18, the comparative prior period figures are reported in the consolidated figures.

BXPHARMA 07-Nov-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

BXPHARMA 13-Nov-2017

(Q1 Un-audited): EPS was Tk. 1.59 for July-September, 2017 as against Tk. 1.27 for July-September, 2016; NOCFPS was Tk. 1.56 for July-September, 2017 as against Tk. 1.62 for July-September, 2016. NAV per share was Tk. 63.36 as on September 30, 2017 and Tk. 60.97 as on September 30, 2016.

BXPHARMA 07-Nov-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

BXPHARMA 15-Nov-2016

(Q1 Un-audited): EPS was Tk. 1.33 for July-September, 2016 as against Tk. 1.09 for July-September, 2015; NOCFPS was Tk. 1.62 for July-September, 2016 as against Tk. 2.09 for July-September, 2015. NAV per share was Tk. 60.97 as of September 30, 2016 and Tk. 56.84 as of September 30, 2015.

BXPHARMA 09-Nov-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2016 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.

BXPHARMA 14-May-2015

(Q1 Un-audited): Profit after tax from Jan'15 to March'15 was Tk. 406.71 million with basic EPS of Tk. 1.11 as against Tk. 329.78 million and Tk. 0.90 respectively for the same period of the previous year. However, considering proposed bonus share @ 5% for the year 2014, restated basic EPS will be Tk. 1.05 as on 31.03.2015 and Tk. 0.85 as on 31.03.2014.

BXPHARMA 14-May-2014

(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2014 (Jan'14 to March'14), the Company has reported net profit after tax of Tk. 329.78 million with basic EPS of Tk. 0.94 as against Tk. 282.93 million and Tk. 0.81 respectively for the same period of the previous year. However, considering proposed bonus share @ 5% for the year 2013, restated basic EPS will be Tk. 0.90 as on 31.03.2014 and Tk. 0.77 as on 31.03.2013.

Previous Next page